Advances and perspectives in CEA-targeted therapies: From classic biomarker toward actionable therapeutic target

Liangjie Sun1, Guo Zhao1, Jiawei Zhou1

  • 1Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital of Chinese Academy of Medical Sciences Langfang Campus, Langfang 065001, China.

Med (New York, N.Y.)
|February 6, 2026
PubMed

Insights

Carcinoembryonic antigen (CEA) is a tumor biomarker for epithelial cancers. This review explores CEA-targeted therapies, including antibody-drug conjugates and CAR T-cells, to overcome challenges and improve patient outcomes.

Area of Science:

  • Oncology
  • Immunotherapy
  • Drug Development

Background:

  • Carcinoembryonic antigen (CEA) is a well-established tumor biomarker for epithelial malignancies.
  • CEA's restricted tumor expression and role in cellular adhesion make it a promising therapeutic target.
  • Challenges have historically hindered the translation of CEA into effective therapies.

Purpose of the Study:

  • To provide a comprehensive review of CEA-targeted therapies.
  • To delineate the landscape and evaluate the prospects of various CEA-targeted drug modalities.
  • To identify and propose strategies to overcome challenges in CEA-targeted therapy development.

Main Methods:

  • Leveraged peer-reviewed literature and global pharmaceutical data.
  • Reviewed antibody-drug conjugates, chimeric antigen receptor T cells, bispecific antibodies, vaccines, and radionuclide conjugates.
  • Dissected underlying mechanisms of challenges in CEA-targeted therapies.

Main Results:

  • Identified diverse CEA-targeted drug modalities with therapeutic potential.
  • Highlighted significant challenges impeding the clinical translation of these therapies.
  • Proposed innovative strategies to address identified obstacles.

Conclusions:

  • CEA holds significant promise as a therapeutic target beyond its diagnostic role.
  • Overcoming specific challenges is crucial for advancing CEA-targeted therapies.
  • This review aims to facilitate CEA's transition to a viable therapeutic target for improved patient outcomes in CEA-expressing cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.4K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Classical Conditioning01:18

Classical Conditioning

Associative learning, a core principle in behavioral psychology, involves forming connections between events and facilitating learned responses. This concept is vividly illustrated by classical conditioning, a process extensively studied by the Russian physiologist Ivan Pavlov. Pavlov's pioneering research on dogs' digestive systems led to the discovery that behaviors can be learned through association, laying the groundwork for classical conditioning.
Ivan Pavlov observed that dogs...
2.3K
Psychodynamic Perspectives on Personality01:27

Psychodynamic Perspectives on Personality

The psychodynamic perspective in psychology asserts that most personality functions operate unconsciously, outside of awareness. This means that the motives and emotions driving behavior often remain hidden, automatically buried in the unconscious mind as a defense mechanism to shield us from psychological distress. According to this theory, the unconscious mind contains thoughts, memories, and emotions that are too disturbing to face directly.
Psychodynamic theorists argue that unconscious...
1.6K
Principles of Classical Conditioning01:23

Principles of Classical Conditioning

Classical conditioning, as described by Ivan Pavlov, is a foundational concept in associative learning, where a neutral stimulus becomes capable of eliciting a conditioned response through association with an unconditioned stimulus. The process of acquisition, where this learning occurs, and the subsequent phenomena of contiguity, contingency, generalization, discrimination, extinction, and spontaneous recovery are crucial for a comprehensive understanding of classical conditioning.
During the...
1.9K